CytomX Therapeutics Inc
CTMX
Market Cap$74.85M
Close$
$6.51
205.8% upside
Current Fair Value
205.8% upsideUndervalued by 205.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $74.85 Million |
|---|---|
| Enterprise Value | $113.38 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.38 |
| Beta | 1.11 |
| Outstanding Shares | 80,099,889 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 2.33 |
|---|---|
| PEG | 2.54 |
| Price to Sales | 2.13 |
| Price to Book Ratio | -2.13 |
| Enterprise Value to Revenue | 0.9 |
| Enterprise Value to EBIT | 16.9 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.68 |
| Debt to Equity | -167.95 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CytomX Therapeutics Inc
CEO: Sean McCarthy